ArticleCancer discovery2023

BCL2 Inhibition Reveals a Dendritic Cell-Specific Immune Checkpoint That Controls Tumor Immunosurveillance.

Liwei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.